title: Surveillance of adamantane resistance among influenza A H3 viruses isolated in Argentina between 2001 and 2007.
abstract: A dramatic rise in the frequency of resistance to adamantane drugs by influenza A H3 viruses, associated with a single amino acid replacement in the viral matrix M2 protein, has occurred in multiple countries worldwide in recent years. We investigated the frequency of adamantane-resistant influenza A H3 viruses in Argentina during the period 2001-2007. We used reverse transcription followed by polymerase chain reaction. The obtained products were sequenced for the detection of mutations of the M2 gere relevant to the resistance phenotypes. The HA1 sequences of the sensitive and resistant strains were also analyzed to clarify whether they had any relevance to the resistant mutations. Twenty out of 55 (36%) strains were identified with the resistance-conferring substitution at amino acid 31 (Serine 31 Asparagine). No resistant viruses were detected between 2001 and 2005. All strains isolated in 2006 and four out of five isolates from 2007 were resistant. None of the patients had received previous treatment with amantadine and/or rimantadine. The HA1 analysis showed that there were only two changes (Serine193 Phenylalanine and Aspartic acid 225 Asparagine) present in the strains with the M2 substitution at position 31. Our data indicate that since 2006 there has been a significant increase of adamantane-resistant influenza A H3 viruses, which raises concern over the spread of these viruses in Argentina.
authors.affiliation: National Influenza Center PAHO/WHO, Servicio Virosis Respiratorias, Departamento Virología, Institute Nacional de Enfermedades Infecciosas, ANLIS Malbrán, Buenos Aires, Argentina. aponto@anlis.gov.ar
authors.forename: A
authors.initials: A
authors.lastname: Pontoriero
authors.forename: E
authors.initials: E
authors.lastname: Baumeister
authors.forename: A M
authors.initials: AM
authors.lastname: Campos
authors.forename: A
authors.initials: A
authors.lastname: Moreno
authors.forename: M E
authors.initials: ME
authors.lastname: Cadario
authors.forename: V
authors.initials: V
authors.lastname: Savy
mesh_terms: D000218:Adamantane / Q000494:pharmacology*; D001118:Argentina; D024882:Drug Resistance, Viral; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects* / Q000302:isolation & purification; D013997:Time Factors
chemical_list: D000218:Adamantane